Endocrinology News and Research

Latest Endocrinology News and Research

Study may help explain why antipsychotic drugs can promote overeating, weight gain

Research to be presented at the upcoming annual meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, may explain why some antipsychotic drugs can promote overeating, weight gain, and insulin resistance.

12 Jul 2011

Epidemiologic and physiologic research on sedentary behavior

Lack of physical exercise is often implicated in many disease processes. However, sedentary behavior, or too much sitting, as distinct from too little exercise, potentially could be a new risk factor for disease.

12 Jul 2011

Study confirms link between phthalates and thyroid hormone levels in humans

A link between chemicals called phthalates and thyroid hormone levels was confirmed by the University of Michigan in the first large-scale and nationally representative study of phthalates and BPA in relation to thyroid function in humans.

12 Jul 2011

Cardiology study looks at sodium and potassium in diet

A new study suggests that in addition to cutting the amount of sodium in their diets to improve heart health, Americans should also increase consumption of a key mineral found in many fruits and vegetables, potassium.

11 Jul 2011

A 16 pound baby born in Texas

A Texas baby was born with a birth weight of 16 pounds and one ounce. JaMichael Brown's weight was more than double the national average for a newborn and he measures 24 inches long, just a few inches shy of an average one-year-old. He is the biggest baby ever born at Good Shepherd Medical Center in Longview, located on the border between Texas and Louisiana. The hospital has been open since 1938 and last year delivered nearly 2,900 babies.

11 Jul 2011

People with long term debilitating physical illness demonstrate mental resilience

People who have a long term debilitating physical illness demonstrate mental resilience according to Understanding Society, the world's largest longitudinal household study. The first findings reveal that people diagnosed with cancer, diabetes, respiratory or cardiovascular disease report similar mental health scores to those without physical illness.

11 Jul 2011

State roundup: Recurring SustiNet rumors in Conn.

The tentative concession deal negotiated between Gov. Dannel P. Malloy's administration and state employee unions is dead. But suspicions it was linked the SustiNet plan to create state-run insurance live on, complicating chances of striking a new deal to avert up to 6,500 layoffs. ... One simple, incontrovertible fact is that there is no SustiNet coverage plan into which state employees can be enticed or forced. But from there, the picture gets fuzzy.

11 Jul 2011

iBio successfully produces human plasma proteins using proprietary technology

iBio, Inc. today announced successful production of human plasma proteins using its proprietary iBioLaunch technology. Human alpha 1-antitrypsin and human C1 esterase inhibitor were successfully produced at high yield in green plants via the Company's proprietary iBioLaunch technology. Both of these proteins are important therapeutic products, but until now they have been made from human blood.

11 Jul 2011

People with long term debilitating physical illness demonstrate mental resilience

People who have a long term debilitating physical illness demonstrate mental resilience according to Understanding Society, the world's largest longitudinal household study.

11 Jul 2011

Randox launches Lab Tests Blog

Randox Laboratories is excited to announce the launch of its very own online blog - Lab Tests Blog.

From Randox Laboratories Ltd. 11 Jul 2011

Global variation in relative burden of stroke and heart disease

An analysis of heart disease and stroke statistics collected in 192 countries by the World Health Organization (WHO) shows that the relative burden of the two diseases varies widely from country to country and is closely linked to national income, according to researchers at the University of California, San Francisco.

11 Jul 2011

Positive top-line results from alemtuzumab Phase 3 trial on multiple sclerosis

Sanofi and its subsidiary Genzyme announced today positive top-line results from CARE-MS I, the first of two randomized, Phase 3 clinical trials comparing the investigational drug alemtuzumab to the approved multiple sclerosis therapy Rebif in patients with relapsing-remitting multiple sclerosis.

11 Jul 2011

Preliminary results from Generex Oral-lyn clinical trial on type 1 diabetes

Generex Biotechnology Corporation today announced preliminary clinical results of two major trials using the Generex Oral-lyn formulation that will be used for registration and marketing.

11 Jul 2011

AJMS summarizes developments related to idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a common and severe lung disease of unknown cause and with no proven therapies. But researchers are pushing forward in investigating new clues to the development and effective treatment of IPF, according to a special symposium presented in The American Journal of the Medical Sciences (AJMS), official journal of the Southern Society for Clinical Investigation (SSCI).

8 Jul 2011

Study finds higher rate of switching from Byetta to Victoza in treatment of type 2 diabetes

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that although Amylin/Eli Lilly's Byetta currently commands a higher patient share than Novo Nordisk's Victoza, more patients were switched from Byetta to Victoza than vice versa (25.2 percent versus 2.8 percent) in the last quarter of 2010 among recently treated type 2 diabetes patients.

8 Jul 2011

Mesenchymal stem cells protect and heal

A stem cell that can morph into a number of different tissues is proving a natural protector, healer and antibiotic maker, researchers at Case Western Reserve University and their peers have found.

8 Jul 2011

Merck Serono announces recipients of second Grant for Fertility Innovation

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announces the recipients of its second Grant for Fertility Innovation.

8 Jul 2011

Cortisol hormone controls bile acid recycling process

Nature sees to it that we do not have "too much choler" in our body. A delicately equilibrated regulation system ensures that there is always exactly the right amount of bile in the gallbladder. When we are hungry, our body releases a hormone called cortisol, which is a glucocorticoid. Hepatic cells receive this hormone signal through their cortisol receptors and respond by filling the gallbladder with bile in preparation of the imminent food intake.

8 Jul 2011

Exenatide tQT clinical trial meets pre-specified primary endpoint

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced results from a thorough QT (tQT) study that assessed the potential of exenatide to increase the QT interval across a wide range of plasma concentrations.

8 Jul 2011

Longer looks: Shortage of HIV doctors; Oregon program builds on British model

Of the 3,155 U.S.-based members of the HIV Medicine Assn., 45% are older than 50, according to a March 17 Institute of Medicine report on HIV screening and access to care.

8 Jul 2011